NCT04318041View on ClinicalTrials.gov

Evaluation of the Structural Modification Effect of Diacerein (Artrodar®) in Knee Osteoarthritic Patients

PHASE3RecruitingINTERVENTIONAL
Enrollment

128

Participants

Timeline

Start Date

November 22, 2020

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Knee Osteoarthritis
Interventions
DRUG

Artrodar

"Diacerein (Artrodar):~D1-D28 (1 month): Artrodar (50 mg) 1 x 1 with evening meal D29-end of study (23 months): Artrodar (50 mg) 1 x 2 with meal"

DRUG

Placebos

"Placebo:~D1-D28 (1 month): Placebo 1 x 1 with evening meal D29-end of study (23 months) Placebo 1 x 2 with meal"

Trial Locations (1)

10700

RECRUITING

Siriraj Hospital, Bangkoknoi

All Listed Sponsors
lead

TRB Chemedica

INDUSTRY